Researcher Spotlight: Christopher Strouse, MD

The University of Iowa

Follicular lymphoma (FL) is typically an indolent, or slow-growing, form of non-Hodgkin lymphoma accounts for 20 to 30 percent of all cases on non-Hodgkin lymphoma. Patients diagnosed with FL can typically expect to live with their lymphoma for years, if not decades. Thus, when coming up with a treatment plan for patients with FL, it is important to weigh the desired effects on the patient’s lymphoma without the undesired effects on the patient’s quality of life.

Dr. Christopher Strouse’s LRF research project will investigate whether follicular lymphoma patients who are exposed to less cycles of bendamustine (Bendeka) have a better quality of life.

Dr. Strouse is a current hematology and medical oncology fellow at the University of Iowa. He received his MD from the University of Wisconsin. His goal is to become an expert in the clinical care of patients with lymphoma by researching methods to improve current or future treatments. “I hope to be able to have several relationships with a new generation of researchers,” he says. “Through the mentorship from the LCRMP, I hope to gain insight into the unanswered questions doctors and their patients with lymphoma face, and how to perform research that will provide meaningful answers to these questions.”